triazoles has been researched along with Candidiasis, Genital in 74 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 33 (44.59) | 18.7374 |
1990's | 21 (28.38) | 18.2507 |
2000's | 12 (16.22) | 29.6817 |
2010's | 6 (8.11) | 24.3611 |
2020's | 2 (2.70) | 2.80 |
Authors | Studies |
---|---|
Ramirez, S; Reedy-Cooper, A; Thomas, S | 1 |
Ansari, S; Goodarzi, S; Javidnia, J; Maryami, F; Mirhendi, H; Rasekh-Jahromi, A; Rezaei-Matehkolaei, A; Romeo, O; Shokoohi, G | 1 |
Angora, KE; Djohan, V; Kassi, FK; Kiki-Barro, PC; Konaté, A; Koné, M; Menan, H; Vanga-Bosson, AH; Yavo, W | 1 |
Chowdhary, A; Kathuria, S; Khan, N; Kumar, DA; Meis, JF; Muralidhar, S; Prakash, A; Randhawa, HS; Sharma, C; Singh, PK; Wankhede, S | 1 |
Fan, S; Li, T; Liang, Y; Liu, X; Xu, H; Zhu, Y | 1 |
Ausma, J; Borgers, M; Cauwenbergh, G; Donders, G; Janssens, D; Wouters, L | 1 |
Asticcioli, S; Daturi, R; Matti, C; Nucleo, E; Pagani, L; Sacco, L; Zara, F | 1 |
Ausma, J; Bellen, G; Borgers, M; Donders, G; Hinoul, P; Janssens, D; Vaneldere, J; Verguts, L | 1 |
Nyirjesy, P; Usiskin, K; Ways, K; Zhao, Y | 1 |
Cid Lama, A; Crespo Erchiga, V; Fernández Ballesteros, MD; Gomez-Moyano, E; Lova Navarro, M; Vera Casaño, A | 1 |
Dorrell, L; Edwards, A | 1 |
Bosques, F; Garza, E; González, G; González, GM; Robledo, E; Saldívar, D | 1 |
Bond, C; Grimshaw, J; Ludbrook, A; Mollison, J; Nurbhai, M; Watson, M | 1 |
Arechavala, AI; Bianchi, MH; Negroni, R; Robles, AM; Santiso, G | 1 |
Muller, G; Sobel, JD | 1 |
Nusch, W; Plempel, M | 1 |
Barrett-Bee, KJ; Ryley, JF; Wilson, RG | 1 |
Backx, LJ; Heeres, J; Van Cutsem, J | 1 |
Janssen, PA; Van Cutsem, J; Van Gerven, F; Zaman, R | 1 |
Heeres, J; Hendrickx, R; Van Cutsem, J | 1 |
Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, L; Norris, C; Parmegiani, RM; Yarosh-Tomaine, T | 1 |
Mummaw, NL; Schooley, SL; Stein, GE | 1 |
Hernanz Hermosa, JM; Lázaro Ochaita, P | 1 |
Baquero, F | 1 |
Lin, AN; Searles, GE; Tredget, EE | 1 |
Cruz Talonia, F; García Figueroa, RG; Ramírez Palacios, D; Romero Cabello, R; Sauceda, L | 1 |
Ringdahl, EN | 1 |
Chatwani, A; Nyirjesy, P; Sood, G; Weitz, MV | 1 |
Bond, CM; Grimshaw, JM; Ludbrook, A; Mollison, J; Watson, MC | 3 |
Allcorn, RJ; Scudamore, JA; Tooley, PJ | 1 |
Benrubi, GI; Griffin, CR; Magee, MJ; Parker, R; Slavin, MB | 1 |
Giaquinta, D; Horowitz, BJ; Ito, S | 1 |
Antonacci, B; Cacciapuoti, A; Hare, RS; Loebenberg, D; Menzel, F; Miller, GH; Moss, EL; Norris, C; Parmegiani, R; Yarosh-Tomaine, T | 1 |
Mendling, W | 1 |
Corson, SL; Kapikian, RR; Nehring, R | 1 |
Van Cutsem, J | 1 |
Nixon, SA | 1 |
Arguelles Domenzain, P; Carrión Tizcareño, H; Llaca Rodríguez, V | 2 |
Ackerbauer, H; Meingassner, JG; Mieth, H; Petranyi, G; Schaude, M | 1 |
Ichise, K; Nakajima, T; Okuda, T; Tanio, T | 1 |
Cepický, P; Sosnová, K; Týcová, H; Zwinger, A | 1 |
Doering, PL; Santiago, TM | 1 |
Broekhuizen, FF; Gelbart, SM; Gotwalt, KT; Kellett, AV; Scaglione, NJ; Thomason, JL | 1 |
Meriwether, C; Schmitt, C; Sobel, J | 1 |
Ansmann, EB; Herzog, RE | 1 |
Cooper, K; Marriott, MS; Richardson, K; Tarbit, MH; Troke, PF; Whittle, PJ | 1 |
Brammer, KW; Feczko, JM | 1 |
Brammer, KW; Kutzer, E; Leodolter, S; Oittner, R | 1 |
Moebius, UM | 1 |
Burke, J; Cope, NJ; Johnson, EM; von Fraunhofer, NA; Warnock, DW; Williams, EW | 1 |
Brammer, KW; Marriott, MS; Richardson, K; Troke, PF | 1 |
Boyle, FT; Gilman, DJ; Gravestock, MB; Wardleworth, JM | 1 |
McGregor, S; Ryley, JF; Wilson, RG | 1 |
Kjaeldgaard, A | 1 |
Martinek, G | 1 |
Delecour, M | 1 |
Nahmanovici, C | 1 |
Goormans, E | 1 |
Grice, G; Kinghorn, GR; Spencer, RC; Steele, CE | 1 |
Siedentopf, HG | 1 |
Litschgi, M | 1 |
Cartwrigth, RY | 1 |
Benijts, G; Dogniez, B; Ubachs, JM; Wesel, S | 1 |
Hiltl, BP; Münnich, W | 1 |
Loendersloot, EW | 1 |
Raab, W | 1 |
10 review(s) available for triazoles and Candidiasis, Genital
Article | Year |
---|---|
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cost-Benefit Analysis; Female; Humans; Imidazoles; Randomized Controlled Trials as Topic; Triazoles | 2007 |
[Superficial mycoses in immunosuppressed patients].
Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles | 1995 |
Treatment of recurrent vulvovaginal candidiasis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Clotrimazole; Drug Interactions; Female; Fluconazole; Humans; Ketoconazole; Patient Education as Topic; Recurrence; Risk Factors; Teaching Materials; Time Factors; Triazoles | 2000 |
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cost-Benefit Analysis; Female; Humans; Imidazoles; Randomized Controlled Trials as Topic; Triazoles | 2001 |
Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush).
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Cost-Benefit Analysis; Female; Humans; Imidazoles; Randomized Controlled Trials as Topic; Triazoles | 2001 |
Oral versus intra-vaginal imidazole and triazole anti-fungal agents for the treatment of uncomplicated vulvovaginal candidiasis (thrush): a systematic review.
Topics: Acute Disease; Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Chronic Disease; Cost-Benefit Analysis; Female; Humans; Imidazoles; Patient Satisfaction; Randomized Controlled Trials as Topic; Triazoles | 2002 |
The treatment of acute and chronic vaginal candidosis.
Topics: Acute Disease; Candidiasis, Vulvovaginal; Chronic Disease; Coloring Agents; Female; Humans; Imidazoles; Polyenes; Triazoles | 1992 |
Evolving pathogens in vulvovaginal candidiasis: implications for patient care.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Female; Humans; Nonprescription Drugs; Ointments; Recurrence; Risk Factors; Species Specificity; Suppositories; Triazoles | 1992 |
[Some new aspects of vaginal candidosis in the female].
Topics: Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Humans; Immune Tolerance; Immunoglobulin A; T-Lymphocytes; Triazoles | 1992 |
Drugs for treatment of vulvovaginal candidiasis: comparative efficacy of agents and regimens.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Costs and Cost Analysis; Female; Humans; Imidazoles; Miconazole; Pregnancy; Pregnancy Complications, Infectious; Triazoles | 1990 |
21 trial(s) available for triazoles and Candidiasis, Genital
Article | Year |
---|---|
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Treatment Outcome; Triazoles; Young Adult | 2015 |
Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: an exploratory phase IIa trial.
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Microscopy; Secondary Prevention; Triazoles | 2008 |
Evaluation of vulvovaginal symptoms and Candida colonization in women with type 2 diabetes mellitus treated with canagliflozin, a sodium glucose co-transporter 2 inhibitor.
Topics: Antifungal Agents; Blood Glucose; Canagliflozin; Candida; Candidiasis, Vulvovaginal; Diabetes Mellitus, Type 2; Female; Glucosides; Humans; Hypoglycemic Agents; Middle Aged; Pyrazines; Sitagliptin Phosphate; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Triazoles; Vagina | 2012 |
Prevention of recurrent vaginal candidiasis with weekly terconazole cream.
Topics: Adult; Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Time Factors; Triazoles; Vaginal Creams, Foams, and Jellies | 1996 |
[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Pyridones; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study.
Topics: Administration, Intravaginal; Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Middle Aged; Pilot Projects; Placebos; Suppositories; Tablets; Time Factors; Triazoles | 1992 |
Terconazole and miconazole cream for treating vulvovaginal candidiasis. A comparison.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Middle Aged; Recurrence; Triazoles | 1991 |
[Terconazol in vaginal candidiasis. Comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
[Terconazole in vaginal candidiasis. A comparative study].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Triazoles | 1990 |
Terconazole for the treatment of vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Double-Blind Method; Female; Humans; Miconazole; Suppositories; Triazoles | 1990 |
Comparison of 0.8% and 1.6% terconazole cream in severe vulvovaginal candidiasis.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Chemistry, Pharmaceutical; Double-Blind Method; Female; Humans; Middle Aged; Random Allocation; Triazoles; Vaginal Creams, Foams, and Jellies | 1990 |
A comparison of single-dose oral fluconazole with 3-day intravaginal clotrimazole in the treatment of vaginal candidiasis. Report of an international multicentre trial.
Topics: Administration, Intravaginal; Administration, Oral; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Drug Administration Schedule; Female; Fluconazole; Humans; Imidazoles; Multicenter Studies as Topic; Triazoles | 1989 |
Treatment of vaginal candidiasis with a single oral dose of fluconazole. Multicentre Study Group.
Topics: Administration, Oral; Adolescent; Adult; Aged; Candida albicans; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Fluconazole; Humans; Middle Aged; Triazoles | 1988 |
Single-dose oral fluconazole in the treatment of vaginal candidosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Fluconazole; Humans; Ketoconazole; Triazoles | 1988 |
A comparison of fluconazole and ketoconazole in the oral treatment of vaginal candidiasis; report of a double-blind multicentre trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Female; Fluconazole; Humans; Ketoconazole; Middle Aged; Multicenter Studies as Topic; Random Allocation; Recurrence; Triazoles | 1988 |
Comparison of terconazole and clotrimazole vaginal tablets in the treatment of vulvovaginal candidosis.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Drug Administration Schedule; Female; Humans; Imidazoles; Random Allocation; Tablets; Triazoles; Vagina | 1986 |
Summary of clinical studies with vaginal formulations of terconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies | 1985 |
Advantages of a 6- to 7-day treatment with 40-mg vaginal suppositories of terconazole against vaginal candidosis: conclusions drawn from a phase II multicentre study in France.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Female; Humans; Recurrence; Suppositories; Time Factors; Triazoles; Vagina | 1985 |
Treatment of vaginal candidosis with three 80-mg terconazole vaginal suppositories: results of a multicentre study in France.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Double-Blind Method; Female; France; Humans; Middle Aged; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Triazoles | 1985 |
Comparative double-blind evaluation of the efficacy and tolerability of terconazole 240-mg suppository (1 day) and 80-mg suppositories (3 days) versus clotrimazole 200-mg (3 days) in pregnant patients with vulvovaginal candidosis.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Double-Blind Method; Female; Humans; Imidazoles; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Tablets; Triazoles; Vagina | 1985 |
One-day treatment of vaginal candidosis: comparison of terconazole 240-mg suppository with clotrimazole 500-mg vaginal tablet.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clinical Trials as Topic; Clotrimazole; Female; Humans; Imidazoles; Suppositories; Tablets; Triazoles; Vagina | 1985 |
43 other study(ies) available for triazoles and Candidiasis, Genital
Article | Year |
---|---|
Oral vs. Intravaginal Antifungal Treatments for Uncomplicated Vulvovaginal Candidiasis.
Topics: Administration, Intravaginal; Administration, Oral; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Triazoles | 2022 |
Molecular identification and antifungal susceptibility profiles of Candida dubliniensis and Candida africana isolated from vulvovaginal candidiasis: A single-centre experience in Iran.
Topics: Adult; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Female; Fungal Proteins; Humans; Imidazoles; Iran; Membrane Glycoproteins; Microbial Sensitivity Tests; Middle Aged; Prevalence; Triazoles | 2021 |
[In vitro susceptibility of vaginal Candida albicans to antifungal drugs in Abidjan (Ivory Coast)].
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis, Vulvovaginal; Colony Count, Microbial; Cote d'Ivoire; Drug Resistance, Fungal; Female; Humans; Leukorrhea; Microbial Sensitivity Tests; Middle Aged; Triazoles; Young Adult | 2012 |
Candida nivariensis as an etiologic agent of vulvovaginal candidiasis in a tertiary care hospital of New Delhi, India.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; DNA, Fungal; Drug Resistance, Fungal; Echinocandins; Female; Fluconazole; Genotype; Humans; India; Itraconazole; Microbial Sensitivity Tests; Nitriles; Phenotype; Phylogeny; Polymerase Chain Reaction; Pyridines; Pyrimidines; Sequence Analysis, DNA; Tertiary Care Centers; Triazoles; Voriconazole; Young Adult | 2013 |
Trends in frequency and in vitro antifungal susceptibility patterns of Candida isolates from women attending the STD outpatients clinic of a tertiary care hospital in Northern Italy during the years 2002-2007.
Topics: Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Italy; Microbial Sensitivity Tests; Outpatient Clinics, Hospital; Prevalence; Pyrimidines; Recurrence; Triazoles; Vagina; Voriconazole | 2009 |
The effect of antifungal treatment on the vaginal flora of women with vulvo-vaginal yeast infection with or without bacterial vaginosis.
Topics: Administration, Oral; Antifungal Agents; Bacteria; Candidiasis, Vulvovaginal; Female; Fluconazole; Humans; Imidazoles; Triazoles; Vaginosis, Bacterial | 2011 |
[Efficacy of voriconazole treatment in chronic vulvovaginal candidosis due to Candida glabrata].
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis, Vulvovaginal; Cesarean Section; Drug Evaluation; Drug Resistance, Multiple, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Pregnancy; Puerperal Disorders; Pyrimidines; Recurrence; Species Specificity; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2013 |
Vulvovaginitis due to fluconazole resistant Candida albicans following self treatment with non-prescribed triazoles.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Nonprescription Drugs; Self Medication; Triazoles; Vulvovaginitis | 2002 |
Therapeutic efficacy of posaconazole against isolates of Candida albicans with different susceptibilities to fluconazole in a vaginal model.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Colony Count, Microbial; Disease Models, Animal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Triazoles; Vagina | 2007 |
[Identification and susceptibility against fluconazole and albaconazole of 100 yeasts' strains isolated from vaginal discharge].
Topics: Adult; Antifungal Agents; Body Fluids; Candida; Candida albicans; Candida glabrata; Candidiasis, Vulvovaginal; Drug Resistance, Fungal; Female; Fluconazole; Humans; Microbial Sensitivity Tests; Middle Aged; Quinazolines; Triazoles; Trichosporon; Vagina | 2007 |
Comparison of ketoconazole, Bay N7133, and Bay L9139 in the treatment of experimental vaginal candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Imidazoles; Ketoconazole; Rats; Rats, Inbred Strains; Triazoles | 1983 |
[Microbiological determination of the oral antifungal agent Bay N 7133 and ketoconazole in cervical and vaginal secretion of patients].
Topics: Administration, Oral; Adult; Antifungal Agents; Biological Assay; Candida; Candidiasis, Vulvovaginal; Cervix Mucus; Female; Humans; Ketoconazole; Leukorrhea; Triazoles | 1983 |
Azole resistance in Candida albicans.
Topics: Amino Acids; Animals; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Ergosterol; Female; Ketoconazole; Mice; Rats; Triazoles | 1984 |
Antimycotic azoles. 7. Synthesis and antifungal properties of a series of novel triazol-3-ones.
Topics: Animals; Antifungal Agents; Aspergillus fumigatus; Candida; Candidiasis, Vulvovaginal; Cryptococcus neoformans; Dermatomycoses; Female; Guinea Pigs; Itraconazole; Ketoconazole; Microsporum; Phialophora; Rats; Rats, Inbred Strains; Sporothrix; Triazoles; Trichophyton | 1984 |
Terconazole - a new broad-spectrum antifungal.
Topics: Administration, Oral; Animals; Antifungal Agents; Candidiasis; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Dermatomycoses; Dose-Response Relationship, Drug; Female; Fungi; Guinea Pigs; Male; Mice; Rats; Rats, Inbred Strains; Triazoles; Trichomonas Vaginitis; Turkeys; Yeasts | 1983 |
Antimycotic azoles. 6. Synthesis and antifungal properties of terconazole, a novel triazole ketal.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Guinea Pigs; Rats; Triazoles | 1983 |
Sch 39304, a new antifungal agent: oral and topical treatment of vaginal and superficial infections.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluconazole; Guinea Pigs; Miconazole; Tinea; Triazoles | 1993 |
[Antifungal drugs: the new frontier].
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Candidiasis, Vulvovaginal; Caspofungin; Drug Resistance, Microbial; Echinocandins; Female; Fungi; Humans; Lipopeptides; Male; Mycoses; Peptides; Peptides, Cyclic; Pyrimidines; Research; Triazoles; Trypanocidal Agents; Voriconazole | 1998 |
Fatal toxic epidermal necrolysis associated with use of terconazole vaginal suppository.
Topics: Administration, Intravaginal; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Fatal Outcome; Female; Humans; Multiple Organ Failure; Stevens-Johnson Syndrome; Triazoles | 1998 |
Terconazole cream for non-Candida albicans fungal vaginitis: results of a retrospective analysis.
Topics: Antifungal Agents; Boric Acids; Candidiasis, Vulvovaginal; Female; Flucytosine; Humans; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Vaginal Creams, Foams, and Jellies | 2000 |
In vitro and in vivo activities of SCH 42427, the active enantiomer of the antifungal agent SCH 39304.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Candidiasis; Candidiasis, Vulvovaginal; Cricetinae; Dermatomycoses; Female; Fungi; Guinea Pigs; Male; Mesocricetus; Mice; Microbial Sensitivity Tests; Rats; Rats, Inbred Strains; Stereoisomerism; Triazoles; Trichophyton | 1992 |
The in vitro activity of terconazole against yeasts: its topical long-acting therapeutic efficacy in experimental vaginal candidiasis in rats.
Topics: Administration, Topical; Amphotericin B; Animals; Antifungal Agents; Candida; Candidiasis, Vulvovaginal; Clotrimazole; Econazole; Female; Miconazole; Microbial Sensitivity Tests; Nystatin; Rats; Rats, Inbred Strains; Triazoles | 1991 |
Vulvovaginitis: the role of patient compliance in treatment success.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Imidazoles; Patient Compliance; Patient Education as Topic; Patient Participation; Triazoles | 1991 |
Preclinical antimycotic activity of SDZ 89-485: a new orally and topically effective triazole.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candida albicans; Candidiasis; Candidiasis, Vulvovaginal; Culture Media; Disease Models, Animal; Female; Guinea Pigs; Histoplasmosis; Humans; Mice; Mycoses; Nephritis; Rats; Sporotrichosis; Tinea; Triazoles | 1990 |
In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Candidiasis, Vulvovaginal; Cryptococcosis; Female; Fluconazole; Guinea Pigs; Male; Mice; Mice, Inbred Strains; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1990 |
[Therapy of mycotic colpitis with terconazole (Gyno-Terazol)].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1990 |
Treatment of vaginal candidosis with fluconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Follow-Up Studies; Humans; Triazoles | 1989 |
Design and evaluation of a systemically active agent, fluconazole.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Drug Design; Female; Fluconazole; Humans; Mice; Molecular Structure; Structure-Activity Relationship; Triazoles | 1988 |
Influenza-like syndrome after terconazole.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Drug Hypersensitivity; Female; Humans; Middle Aged; Triazoles | 1988 |
Fluconazole resistance in Candida glabrata.
Topics: Antifungal Agents; Bile; Candida; Candidiasis; Candidiasis, Vulvovaginal; Drug Resistance, Microbial; Female; Fluconazole; Humans; Middle Aged; Triazoles; Urine | 1988 |
Activity of UK-49,858, a bis-triazole derivative, against experimental infections with Candida albicans and Trichophyton mentagrophytes.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Candidiasis, Vulvovaginal; Dermatomycoses; Female; Fluconazole; Guinea Pigs; Immunosuppression Therapy; Ketoconazole; Mice; Rats; Rats, Inbred Strains; Tinea; Triazoles | 1985 |
Synthesis and structure-activity relationships of a novel antifungal agent, ICI 195,739.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis, Vulvovaginal; Female; Mice; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship; Triazoles | 1988 |
Terconazole for Candida vaginitis.
Topics: Administration, Intravaginal; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Suppositories; Triazoles; Vaginal Creams, Foams, and Jellies | 1988 |
Activity of ICI 195,739--a novel, orally active bistriazole--in rodent models of fungal and protozoal infections.
Topics: Animals; Antifungal Agents; Antiprotozoal Agents; Candidiasis, Vulvovaginal; Disease Models, Animal; Drug Evaluation, Preclinical; Female; Malaria; Mice; Rats; Structure-Activity Relationship; Tinea; Triazoles; Trypanosomiasis | 1988 |
Antifungals in gynaecology: focus on terconazole. International workshop, Frankfurt a.M., September 29, 1984.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1985 |
Antifungals in gynaecology: focus on terconazole. Rationale for single-dose therapy.
Topics: Candidiasis, Vulvovaginal; Drug Administration Schedule; Female; Humans; Pregnancy; Triazoles | 1985 |
Terconazole 0.8% vaginal cream (5 days) versus clotrimazole 1% (6 days): efficacy and tolerability in an open study.
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Triazoles; Vaginal Creams, Foams, and Jellies | 1985 |
Assessment of clinical efficacy and tolerability of terconazole 240-mg vaginal suppositories.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Pregnancy; Pregnancy Complications, Infectious; Suppositories; Triazoles; Vagina | 1985 |
Terconazole, a new triazole antifungal agent.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Chemical Phenomena; Chemistry; Female; Fungi; Humans; In Vitro Techniques; Pregnancy; Triazoles | 1985 |
Comparative open evaluation of efficacy and tolerability of terconazole 0.8% cream in a 5-day regimen versus clotrimazole 100-mg tablets in a 6-day regimen.
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Middle Aged; Suppositories; Tablets; Triazoles; Vagina | 1985 |
Single-day topical treatment of vaginal candidosis: an open evaluation of terconazole 240-mg vaginal suppositories versus isoconazole tablets 600 mg.
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Miconazole; Suppositories; Tablets; Triazoles; Vagina | 1985 |
Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candido
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Clotrimazole; Female; Humans; Imidazoles; Suppositories; Tablets; Triazoles; Vagina | 1985 |
[Terconazole, a new triazole derivative for the treatment of vaginal mycoses].
Topics: Antifungal Agents; Candidiasis, Vulvovaginal; Female; Humans; Triazoles | 1985 |